Using a 10mg vial reconstituted with 2mL (concentration: 5mg/mL): At 2mg per week: Draw 0.4mL = 40 units
While not a kidney-disease predictor, this test helps personalize your semaglutide or tirzepatide dose to optimize both weight loss and metabolic protection, including kidney function support
Many users of a GLP-1 suffer from plateaus or side effects
Patient experience is contingent on how simple it is to administer the drug, manage side effects, and maintain the treatment in the long term
The primary outcome will be the percentage of participants with 3 step Early Treatment Diabetic Retinopathy Study (ETDRS) subject-level progression at five years, as well as secondary outcomes including 17 ocular and four systemic outcomes
Managing Hypothyroidism and GLP-1 Therapy If you have an underactive thyroid (hypothyroidism) or an autoimmune condition like Hashimotos thyroiditis, you are likely not "disqualified" from taking a GLP-1 medication